Announcements Trials

Browse Landscape

Phase

Status

Recruiting 3 Completed 2 Terminated 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 128 Breast Neoplasms 111 Neoplasms 93 Neoplasm Metastasis 76 Melanoma 70 Colorectal Neoplasms 69 Leukemia, Myeloid, Acute 66 Prostatic Neoplasms 58 Multiple Myeloma 53 Lung Neoplasms 51 Ovarian Neoplasms 49 Squamous Cell Carcinoma of Head and Neck 45 Recurrence 41 Triple Negative Breast Neoplasms 40 Carcinoma, Renal Cell 38 Carcinoma, Hepatocellular 38 Pancreatic Neoplasms 36 Myelodysplastic Syndromes 36 Glioblastoma 34 Brain Neoplasms 34 Stomach Neoplasms 30 Lymphoma, Non-Hodgkin 30 Lymphoma 30 Endometrial Neoplasms 30 Head and Neck Neoplasms 28 Lymphoma, Large B-Cell, Diffuse 27 Leukemia 27 Uterine Cervical Neoplasms 26 Cholangiocarcinoma 26 Urinary Bladder Neoplasms 24

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Advanced Malignancies × 1 year × Clear all

NCT05351697 2026-03-17

BR105-I

BioRay Pharmaceutical Co., Ltd.

Phase 1 Terminated

Advanced Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡